The objective was to evaluate the safety. reactogenicity and immunogenicity of the AMA-1-based blood-stage malaria vaccine FMP2. 1/AS02A in adults exposed to seasonal malaria. A phase 1 double blind randomized controlled dose escalation trial was conducted in Bandiagara. https://parisnaturalfoodes.shop/product-category/rosemary-conditioner/